Department of Immunology and Molecular Medicine, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India.
DNA Cell Biol. 2012 Jan;31(1):74-9. doi: 10.1089/dna.2011.1297. Epub 2011 Jun 28.
The glutathione S-transferase (GST) enzyme encoded by the GSTP1 gene is one of the critical enzymes involved in detoxification of carcinogens. The substitution of isoleucine to valine residue at position 105 of the GSTP1 protein results in decreased enzyme activity and hence less capability of effective detoxification. Hence, we investigated the role of GSTP1 I105V polymorphism in modulating the risk of colorectal cancer (CRC) associated in a Kashmiri population. We designed a case-control study in which 86 CRC cases were studied for GSTP1 I105V polymorphism against 160 controls taken from the general population employing the polymerase chain reaction-restriction length fragment polymorphism technique. There was no significant association between GSTP1 I105V genotypes and the disease, but the Val/Val genotype was associated with an increased risk with some clinicopathological parameters (odds ratio=1.5; 95% confidence interval=0.55-4.57). This study suggests that the GSTP1 I105V polymorphism may modulate CRC risk in the Kashmiri population.
谷胱甘肽 S-转移酶(GST)酶由 GSTP1 基因编码,是参与解毒致癌物的关键酶之一。 GSTP1 蛋白第 105 位异亮氨酸替换为缬氨酸残基会导致酶活性降低,从而降低有效解毒的能力。因此,我们研究了 GSTP1 I105V 多态性在调节克什米尔人群中与结直肠癌(CRC)相关的风险中的作用。我们设计了一项病例对照研究,其中 86 例 CRC 病例与从普通人群中选择的 160 例对照进行 GSTP1 I105V 多态性研究,采用聚合酶链反应-限制性片段长度多态性技术。 GSTP1 I105V 基因型与疾病之间没有显著关联,但 Val/Val 基因型与某些临床病理参数相关联(比值比=1.5;95%置信区间=0.55-4.57)。这项研究表明,GSTP1 I105V 多态性可能调节克什米尔人群中 CRC 的风险。